Bell Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Buy
962
+24
+3% +$8.9K 0.05% 101
2026
Q1
$275K Buy
938
+15
+2% +$4.93K 0.04% 107
2025
Q4
$323K Sell
923
-19
-2% -$6.42K 0.05% 96
2025
Q3
$304K Sell
942
-77
-8% -$23.9K 0.05% 101
2025
Q2
$396K Buy
1,019
+29
+3% +$11.7K 0.07% 87
2025
Q1
$430K Buy
990
+36
+4% +$14.5K 0.08% 72
2024
Q4
$352K Sell
954
-75
-7% -$31.4K 0.07% 80
2024
Q3
$535K Hold
1,029
0.1% 66
2024
Q2
$557K Buy
1,029
+26
+3% +$13.7K 0.11% 62
2024
Q1
$520K Buy
1,003
+14
+1% +$6.96K 0.1% 64
2023
Q4
$466K Buy
989
+20
+2% +$9.25K 0.1% 62
2023
Q3
$422K Buy
969
+7
+0.7% +$3.17K 0.09% 64
2023
Q2
$427K Buy
962
+8
+0.8% +$3.69K 0.09% 60
2023
Q1
$439K Sell
954
-12
-1% -$5.71K 0.1% 59
2022
Q4
$495K Buy
966
+820
+562% +$416K 0.12% 53
2022
Q3
$66K Buy
146
+14
+11% +$6.7K 0.02% 106
2022
Q2
$64K Buy
+132
New +$65.3K 0.02% 112
2021
Q4
$59K Buy
128
+28
+28% +$11.8K 0.02% 140
2021
Q3
$37K Buy
+100
New +$38K 0.01% 177

Other funds holding ELV

Bell Investment Advisors's ELV Position: Q2 2026 in Review

Bell Investment Advisors increased its Elevance Health (ELV) stake by 2.6% in Q2 2026, buying an estimated $8.9K and bringing the position to 962 shares worth $372K. The position accounts for 0.05% of the portfolio, ranked #101.

Bell Investment Advisors first reported a position in ELV in Q3 2021 and has held it in 19 quarters since. The position peaked at $557K in Q2 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Bell Investment Advisors held 962 shares of Elevance Health worth $372K as of Q2 2026.
  • Bell Investment Advisors bought 24 Elevance Health shares in Q2 2026, an estimated $8.9K.
  • Elevance Health made up 0.05% of Bell Investment Advisors's portfolio in Q2 2026, its #101 holding.
  • Bell Investment Advisors first reported a position in Elevance Health in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Elevance Health position peaked at $557K in Q2 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.